IFNG and neoplasm: In future experiments, we will test if these fusions are similarly effective in targeting RCC cells in vivo, where IFN-γ’s direct anti-tumor effects – and its pro-necrotic ability in particular - can be exploited without significant toxicity issues arising from systemic distribution of IFN-γ.